Adicet Bio, Inc. ACET
9.02
0.75
9.07%
as of 25 Sep
- Market cap
- $77.4M
- P/E
- 0.0×
Follow ACET
Insider Buys
alert about insiders buying in the last 12 month
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/S ratio |
0.00 | 0.00 | 5.74 | 5.49 | 55.64 | 58.31 | 9.10 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/Operating CF |
(3.07) | (2.91) | (7.71) | (7.36) | (40.27) | (42.20) | (18.69) | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.94 | 0.89 | 1.79 | 1.87 | 1.20 | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 1.15 | 1.09 | 1.91 | 2.00 | 1.29 | — | — | — |
EV/Sales |
0.00 | 0.00 | 1.60 | 1.34 | 29.10 | 31.78 | 2.92 | — | — | — |
EV/EBITDA |
1.32 | 1.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
1.44 | 1.48 | (0.69) | (0.58) | (5.55) | (6.06) | (2.52) | — | — | — |
EV/FCF |
1.39 | 1.43 | (0.67) | (0.57) | (4.42) | (4.82) | (1.83) | — | — | — |
Quick Ratio |
4.20 | 4.33 | 4.21 | 17.02 | 17.02 | 13.10 | 13.07 | 8.28 | 9.09 | 7.36 |
Current Ratio |
4.32 | 4.46 | 4.46 | 17.31 | 17.31 | 13.25 | 13.25 | 8.41 | 9.29 | 7.47 |
Net Debt/EBITDA |
2.06 | 2.46 | 2.50 | 4.50 | 4.65 | 3.54 | 3.69 | 1.26 | 1.44 | 1.32 |
Debt/Assets |
0.00% | 13.28% | 0.00% | 5.72% | 0.00% | 5.60% | 0.00% | 0.00% | 0.00% | 0.33% |
Debt/Equity |
0.00 | 0.19 | 0.00 | 0.06 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.01 | 0.15 | 0.12 | 0.04 | 0.03 | 0.07 | 0.08 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.99 | 1.14 | 1.13 | 0.83 | 0.82 | 0.65 | 0.64 | 0.66 | 0.79 | 0.82 |
Capex/Depreciation |
(0.91) | 0.00 | (0.73) | 0.00 | (7.57) | 0.00 | (6.29) | (0.17) | (0.23) | (0.75) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 46.61% | (148.31%) | (33.40%) | (30.03%) | (20.45%) | (23.44%) | (23.87%) | (61.69%) | (65.65%) | (67.55%) | |
| (34.49%) | (31.16%) | (23.84%) | (25.16%) | (18.29%) | (20.84%) | (21.10%) | (53.03%) | (54.79%) | (56.62%) | |
ROIC |
0.00% | 0.00% | (161.01%) | 0.00% | (150.07%) | 0.00% | (130.74%) | (908.10%) | (773.91%) | (5,773.17%) |
Return on Tangible Assets |
(54.70%) | (35.36%) | (45.48%) | (20.59%) | (22.08%) | (24.04%) | (25.84%) | (84.03%) | (63.91%) | (74.91%) |
Average Days of Receivables |
0.00 | 55.68 | 0.00 | 8.03 | 6.94 | 6.35 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
2,381.01% | 191.78% | 191.78% | 503.01% | 503.01% | 285.10% | 285.10% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
873.57% | 76.57% | 127.13% | 186.57% | 228.37% | 85.18% | 105.22% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.14 | 0.13 | 0.06 | 0.06 | 0.06 | 0.06 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
118.09% | 0.00% | 29.40% | 0.00% | 128.58% | 0.00% | 68.53% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(3.49) | (3.68) | 0.55 | 0.57 | 0.46 | 0.43 | 0.63 | — | — | — |
Graham Number |
1,740.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Earnings Yield |
(178.62%) | (188.75%) | (65.89%) | (68.98%) | (11.84%) | (11.29%) | (19.72%) | — | — | — |
Free Cash Flow Yield |
(129.23%) | (136.56%) | (41.36%) | (43.31%) | (11.84%) | (11.30%) | (17.48%) | — | — | — |
Revenue per Share |
7.44 | 2.45 | 39.13 | 0.31 | 5.03 | 0.61 | 9.73 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(208.54) | (5.70) | (90.82) | (1.66) | (26.39) | (1.10) | (17.44) | (34.84) | (16.82) | (13.82) |
Capex per Share |
(7.12) | 0.00 | (2.16) | 0.00 | (6.74) | 0.00 | (6.54) | (1.66) | (0.20) | (0.25) |
Free Cash Flow per Share |
(215.66) | (5.70) | (92.99) | (1.66) | (33.13) | (1.10) | (23.97) | (36.50) | (17.02) | (14.07) |
Cash per Share |
466.72 | 12.93 | 206.81 | 8.97 | 143.47 | 6.27 | 100.35 | 59.37 | 32.10 | 23.00 |
Shareholders Equity per Share |
(451.50) | 15.00 | 240.06 | 9.79 | 156.70 | 7.12 | 113.86 | 63.26 | 33.98 | 23.10 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(451.50) | 15.00 | 240.06 | 9.79 | 156.70 | 7.12 | 113.86 | 63.26 | 33.98 | 23.10 |
Free Cash Flow |
(28.83) | (41.71) | (42.54) | (51.31) | (64.10) | (45.13) | (61.55) | (98.18) | (93.50) | (96.98) |
Working Capital |
49.32 | 77.86 | 77.86 | 266.12 | 266.12 | 241.33 | 241.33 | 142.99 | 160.74 | 139.40 |
Capital Expenditures |
(0.95) | (0.99) | (0.99) | (13.05) | (13.05) | (16.78) | (16.78) | (4.46) | (1.12) | (1.74) |
Net Current Asset Value |
(77.77) | 56.33 | 56.33 | 246.63 | 246.63 | 222.69 | 222.69 | 125.15 | 146.53 | 127.78 |
EV/EBIT |
1.28 | 1.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.96 | 0.00 | 0.06 | 0.00 | 1.34 | 0.00 | 0.67 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(2,827.94%) | (204.87%) | (204.87%) | (637.19%) | (637.19%) | (279.27%) | (279.27%) | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.49 | 0.08 | 0.49 | 0.12 | 0.12 | 0.10 | 0.09 | 0.96 | 0.21 | 0.14 |
Cash ROIC |
(1,475.07%) | (30.05%) | (21.69%) | (14.38%) | (11.31%) | (16.55%) | (13.36%) | (36.53%) | (31.66%) | (35.11%) |
Accounts Receivable Turnover |
0.00 | 9.77 | 0.00 | 6.61 | 48.77 | 80.61 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 0.00 | — | — | — | — |
Average Receivables |
— | 1.83 | — | 1.47 | 0.20 | 0.31 | — | — | — | — |
Average Payables |
1.05 | 1.30 | 1.55 | 2.41 | 3.26 | 3.83 | 4.40 | 3.51 | 3.73 | 4.78 |
Average Assets |
81.59 | 117.71 | 153.84 | 246.39 | 338.94 | 334.81 | 330.69 | 268.99 | 213.76 | 206.29 |
Average Common Equity |
(60.37) | 24.73 | 109.83 | 206.48 | 303.13 | 297.73 | 292.34 | 231.26 | 178.39 | 172.91 |
Columns are period end dates